Reviewing the Range of None-Invasive Biomarker Technologies Available for More Effective NASH Drug Development, Considering Accuracy, Reliability & Patient Centricity

Time: 2:30 pm
day: Post Conference Seminar Day


• Identifying the types of non-invasive biomarkers that can successful discern disease stages/progress
• Update on molecular magnetic resonance imaging (MRI) for NASH fibrosis
• Outlining different non-invasive biomarker types available